|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,413,000 |
Market
Cap: |
8.95(B) |
Last
Volume: |
591,041 |
Avg
Vol: |
504,733 |
52
Week Range: |
$114.17 - $208.42 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
3 |
Total Shares Sold |
23,589 |
45,669 |
50,307 |
151,828 |
Total Sell Value |
$4,058,631 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
Total People Sold |
2 |
4 |
5 |
6 |
Total Sell Transactions |
2 |
5 |
7 |
17 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Witt Daniel P |
Senior Vice President |
|
2014-04-15 |
4/A |
OE |
$3.05 |
$30,500 |
D/D |
10,000 |
57,709 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2014-04-15 |
4/A |
OE |
$3.05 |
$76,250 |
D/D |
25,000 |
151,270 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2014-04-15 |
4 |
B |
$3.05 |
$76,250 |
D/D |
25,000 |
151,270 |
2.74 |
- |
|
Witt Daniel P |
Senior Vice President |
|
2014-04-15 |
4 |
B |
$3.05 |
$30,500 |
D/D |
10,000 |
57,709 |
2.74 |
- |
|
Benjamin Howard |
VP Business Development |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,962 |
28,926 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,644 |
143,914 |
|
- |
|
Witt Daniel P |
Senior Vice President |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,182 |
53,891 |
|
- |
|
Kelly William J |
Chief Accounting Officer |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,456 |
5,456 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
24,639 |
562,432 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2013-08-08 |
4 |
S |
$10.01 |
$300,354 |
D/D |
(30,000) |
137,270 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2013-08-07 |
4 |
D |
$9.83 |
$293,504 |
D/D |
(29,858) |
167,270 |
|
- |
|
Rusche James R |
Senior Vice President |
|
2013-08-07 |
4 |
OE |
$5.87 |
$293,500 |
D/D |
50,000 |
197,128 |
|
- |
|
Dawes Karen A |
Director |
|
2013-06-21 |
4 |
B |
$7.70 |
$7,700 |
D/D |
1,000 |
33,880 |
2.39 |
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-17 |
4 |
S |
$9.00 |
$63,030 |
I/I |
(7,000) |
0 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-17 |
4 |
S |
$8.95 |
$89,524 |
D/D |
(10,000) |
48,380 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-16 |
4 |
S |
$8.95 |
$35,801 |
D/D |
(4,000) |
58,380 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-15 |
4 |
S |
$8.99 |
$17,643 |
D/D |
(1,961) |
62,380 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2013-05-15 |
4 |
S |
$8.85 |
$13,399 |
D/D |
(1,514) |
537,793 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-15 |
4 |
S |
$8.96 |
$133,423 |
D/D |
(14,884) |
58,999 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-15 |
4 |
OE |
$3.10 |
$46,140 |
D/D |
14,884 |
73,883 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2013-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
539,307 |
|
- |
|
Herlihy Walter C |
PRESIDENT, CEO |
|
2013-05-14 |
4 |
S |
$8.98 |
$345,450 |
D/D |
(38,486) |
549,307 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-14 |
4 |
S |
$8.93 |
$153,490 |
D/D |
(17,155) |
58,999 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-14 |
4 |
OE |
$3.10 |
$51,060 |
D/D |
15,116 |
61,154 |
|
- |
|
Ryan Thomas F Jr |
Director |
|
2013-05-13 |
4 |
S |
$9.04 |
$488,263 |
D/D |
(54,000) |
61,038 |
|
- |
|
647 Records found
|
|
Page 20 of 26 |
|
|